Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
VASA. Supplementum|January 1, 1989
Metabolic effects of prostaglandin E1 on human skeletal muscle with special regard to the amino acid metabolismH Stiegler, K Rett, M Wicklmayr, et al.VASA. Supplementum|January 1, 1989
Therapeutic efficacy of intravenously applied prostaglandin E1P Scheffler, D de la Hamette, G LeipnitzVASA. Supplementum|January 1, 1991
[Combined arterial bypass operation and coumarin therapy--a concept for long-term management and its conditions]L Kühnel, C Heinrichs, I Wache, et al.VASA. Supplementum|January 1, 1991
[Hemorheologic therapy of asystematic vertigo]P Spürk, H G Dehnert, B AngelkortVASA. Supplementum|January 1, 1992
[Giant cell arteritis of the arteries of the arm. Diagnosis, surgical indications and choice of procedure]V Mickley, S Hutschenreiter, H Kogel, et al.VASA. Supplementum|January 1, 1992
[Intraoperative morphologic functional evaluation of the arterial outflow tract--its importance for indications for vascular reconstruction of the femoro-crural vascular segment]W Wagemann, Z HalloulVASA. Supplementum|January 1, 1989
Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trialG RudofskyVASA. Supplementum|January 1, 1989
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter studyG Trübestein, S von Bary, K Breddin, et al.VASA. Supplementum|January 1, 1989
Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an updateH Sinzinger, I Virgolini, P FitschaVASA. Supplementum|January 1, 1991
[In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells]R Voisard, P C Dartsch, U Seitzer, et al.Pageof 12